9 Oral: BBO-10203, an orally bioavailable small molecule that disrupts the RAS-PI3Kα interaction leading to pAKT and tumor growth inhibition in models of breast, lung and colorectal cancer
Title:
9 Oral: BBO-10203, an orally bioavailable small molecule that disrupts the RAS-PI3Kα interaction leading to pAKT and tumor growth inhibition in models of breast, lung and colorectal cancer
Author:
Simanshu, D. Xu, R. Stice, J. Czyzyk, D. Feng, S. Yang, Y. Denson, J.P. Riegler, E. Zhang, C. Fu, L. Lin, K. Lightstone, F.C. Wang, K. Stephen, A.G. Maciag, A.E. Sinkevicius, K. Nissley, D.V. Wallace, E.M. McCormick, F. Beltran, P.